Awanye, Amaka M.
Chang, Chun-Mien
Wheeler, Jun X.
Chan, Hannah
Marsay, Leanne
Dold, Christina
Rollier, Christine S.
Bird, Louise E. http://orcid.org/0000-0002-9846-5716
Nettleship, Joanne E.
Owens, Raymond J.
Pollard, Andrew J.
Derrick, Jeremy P. http://orcid.org/0000-0002-4350-5354
Funding for this research was provided by:
TETFund
Taiwan Bio-Development Foundation and The MOE (Taiwan) Technologies Incubation Scholarship
Wellcome Trust (082102/Z/07/A, 082102/Z/07/A)
Article History
Received: 4 October 2018
Accepted: 11 April 2019
First Online: 2 May 2019
Competing Interests
: There was no involvement of any commercial organization in this study. J.P.D. is in receipt of funds from GlaxoSmithKline for vaccine research. He does not receive any personal payments from them or honoraria. A.J.P. has previously conducted clinical trials on behalf of Oxford University funded by manufacturers of meningococcal vaccines including Novartis Vaccines, GlaxoSmithKline, Pfizer and Sanofi Pasteur. He does not receive any personal payments from them nor travel reimbursement or honoraria. His department has received unrestricted educational grants from vaccine manufacturers for organisation of courses and symposia. A.J.P. has previously been named on patents in the field of group B meningococcal vaccines. All the other authors declare no competing interests.